Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.48 |
| ▸ | SCD | O00767 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20694232 | 0.93 | MALT1 (0.45) | MALT1SCDKDM4EALDH1A1MEN1 | |
| SCHEMBL5864916 | 0.86 | SCD (0.56) | SCDALDH1A1MEN1KMT2A | |
| SCHEMBL20694348 | 0.81 | ALDH1A1 (0.50) | MALT1SCDKDM4EALDH1A1MAPT | |
| SCHEMBL5864969 | 0.81 | ALDH1A1 (0.43) | SCDALDH1A1MAPK1LMNAMAPT | |
| SCHEMBL5864832 | 0.81 | SCD (0.56) | MALT1SCDKDM4EALDH1A1MEN1 | |
| SCHEMBL5864962 | 0.79 | SCD (0.42) | SCDALDH1A1LMNAMAPT | |
| SCHEMBL5864814 | 0.79 | SCN8A (0.49) | ALDH1A1LMNA | |
| SCHEMBL5864926 | 0.78 | TRPV6 (0.42) | SCD | |
| SCHEMBL20694342 | 0.77 | ALDH1A1 (0.46) | SCDALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL20694324 | 0.77 | ALDH1A1 (0.49) | MALT1SCDKDM4EALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2650290-A1 | Cyclic amine compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2013-10-16 | — | — | EP | claimed |
| US-7030138-B2 | Benzamidine derivatives | SANKYO COMPANY, LIMITED (JP) | 2006-04-18 | — | — | US | disclosed |
| US-20040147555-A1 | Benzamidine derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-07-29 | — | — | US | disclosed |
| EP-1375482-A1 | BENZAMIDINE DERIVATIVE | Sankyo Company, Limited (JP) | 2004-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147555-A1 | Benzamidine derivatives | F9, F7, F2 | MALT1 1618/4885SCD 2794/4885KDM4E 960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.